HK1166798A1 - Process for preparing an antiviral compound - Google Patents
Process for preparing an antiviral compoundInfo
- Publication number
- HK1166798A1 HK1166798A1 HK12107568.3A HK12107568A HK1166798A1 HK 1166798 A1 HK1166798 A1 HK 1166798A1 HK 12107568 A HK12107568 A HK 12107568A HK 1166798 A1 HK1166798 A1 HK 1166798A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- preparing
- antiviral compound
- antiviral
- compound
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
- C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16270509P | 2009-03-24 | 2009-03-24 | |
| US31671310P | 2010-03-23 | 2010-03-23 | |
| PCT/US2010/028433 WO2010111348A1 (en) | 2009-03-24 | 2010-03-24 | Process for preparing antiviral compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1166798A1 true HK1166798A1 (en) | 2012-11-09 |
Family
ID=42136100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12107568.3A HK1166798A1 (en) | 2009-03-24 | 2012-08-01 | Process for preparing an antiviral compound |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP2411372B1 (ko) |
| JP (1) | JP5744003B2 (ko) |
| KR (1) | KR101665955B1 (ko) |
| CN (1) | CN102361858B (ko) |
| AU (1) | AU2010229975B2 (ko) |
| BR (1) | BRPI1009854A2 (ko) |
| CA (1) | CA2753825C (ko) |
| CL (1) | CL2011002278A1 (ko) |
| CO (1) | CO6450678A2 (ko) |
| CR (1) | CR20110524A (ko) |
| DO (1) | DOP2011000297A (ko) |
| EC (1) | ECSP11011415A (ko) |
| ES (1) | ES2488821T3 (ko) |
| GT (1) | GT201100241A (ko) |
| HK (1) | HK1166798A1 (ko) |
| IL (1) | IL214858A (ko) |
| MX (1) | MX2011010049A (ko) |
| MY (1) | MY169288A (ko) |
| NZ (1) | NZ594923A (ko) |
| PE (1) | PE20120519A1 (ko) |
| RU (1) | RU2524573C2 (ko) |
| SG (1) | SG174211A1 (ko) |
| WO (1) | WO2010111348A1 (ko) |
| ZA (1) | ZA201106511B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9255074B2 (en) | 2010-07-16 | 2016-02-09 | Abbvie Inc. | Process for preparing antiviral compounds |
| KR101774742B1 (ko) | 2010-07-16 | 2017-09-11 | 애브비 아일랜드 언리미티드 컴퍼니 | 촉매 반응용 포스핀 리간드 |
| US8975443B2 (en) | 2010-07-16 | 2015-03-10 | Abbvie Inc. | Phosphine ligands for catalytic reactions |
| JP5819959B2 (ja) | 2010-07-16 | 2015-11-24 | アッヴィ・バハマズ・リミテッド | 抗ウイルス性化合物を調製するための方法 |
| WO2012129099A1 (en) * | 2011-03-18 | 2012-09-27 | Abbott Laboratories | Formulations of phenyl uracil compounds |
| US20160375017A1 (en) | 2015-06-26 | 2016-12-29 | Abbvie Inc. | Solid Pharmaceutical Compositions for Treating HCV |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001021624A1 (fr) * | 1999-09-20 | 2001-03-29 | Fuji Photo Film Co., Ltd. | Composes destines au marquage par fluorescence |
| CZ2002992A3 (cs) * | 1999-09-22 | 2002-06-12 | Aventis Pharma Deutschland Gmbh | Konjugáty 4-benzylaminochinolinů se ľlučovými kyselinami a jejich heteroanalogy, způsob jejich přípravy, farmaceutické prostředky je obsahující, a jejich pouľití |
| DE10051981A1 (de) * | 2000-10-20 | 2002-05-02 | Bayer Ag | Substituierte Phenyluracile |
| EP2038253A1 (en) * | 2006-05-30 | 2009-03-25 | Arrow Therapeutics Limited | Biphenyl derivatives and their use in treating hepatitis c |
| EP2377854A1 (en) * | 2007-09-17 | 2011-10-19 | Abbott Laboratories | N-phenyl-dioxo-hydropyrimidines useful as hepatitis C virus (HCV) inhibitors |
| KR101552474B1 (ko) * | 2007-09-17 | 2015-09-11 | 애브비 바하마스 리미티드 | Ｃ형 간염 치료용 우라실 또는 티민 유도체 |
| KR20110033291A (ko) * | 2008-07-23 | 2011-03-30 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 항바이러스 화합물 |
-
2010
- 2010-03-24 RU RU2011142757/04A patent/RU2524573C2/ru active
- 2010-03-24 CA CA2753825A patent/CA2753825C/en active Active
- 2010-03-24 ES ES10711968.7T patent/ES2488821T3/es active Active
- 2010-03-24 BR BRPI1009854-2A patent/BRPI1009854A2/pt not_active Application Discontinuation
- 2010-03-24 CN CN201080013374.7A patent/CN102361858B/zh active Active
- 2010-03-24 PE PE2011001686A patent/PE20120519A1/es active IP Right Grant
- 2010-03-24 KR KR1020117024825A patent/KR101665955B1/ko active IP Right Grant
- 2010-03-24 MY MYPI2011004471A patent/MY169288A/en unknown
- 2010-03-24 EP EP10711968.7A patent/EP2411372B1/en active Active
- 2010-03-24 NZ NZ594923A patent/NZ594923A/xx unknown
- 2010-03-24 JP JP2012502196A patent/JP5744003B2/ja active Active
- 2010-03-24 MX MX2011010049A patent/MX2011010049A/es active IP Right Grant
- 2010-03-24 SG SG2011063179A patent/SG174211A1/en unknown
- 2010-03-24 WO PCT/US2010/028433 patent/WO2010111348A1/en active Application Filing
- 2010-03-24 AU AU2010229975A patent/AU2010229975B2/en active Active
-
2011
- 2011-08-24 EC EC2011011415A patent/ECSP11011415A/es unknown
- 2011-08-28 IL IL214858A patent/IL214858A/en active IP Right Grant
- 2011-09-06 ZA ZA2011/06511A patent/ZA201106511B/en unknown
- 2011-09-14 CL CL2011002278A patent/CL2011002278A1/es unknown
- 2011-09-20 GT GT201100241A patent/GT201100241A/es unknown
- 2011-09-21 CO CO11123197A patent/CO6450678A2/es active IP Right Grant
- 2011-09-23 DO DO2011000297A patent/DOP2011000297A/es unknown
- 2011-10-04 CR CR20110524A patent/CR20110524A/es unknown
-
2012
- 2012-08-01 HK HK12107568.3A patent/HK1166798A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT201100241A (es) | 2015-08-19 |
| JP2012521990A (ja) | 2012-09-20 |
| KR20110137372A (ko) | 2011-12-22 |
| CN102361858A (zh) | 2012-02-22 |
| JP5744003B2 (ja) | 2015-07-01 |
| CA2753825A1 (en) | 2010-09-30 |
| ES2488821T3 (es) | 2014-08-29 |
| WO2010111348A1 (en) | 2010-09-30 |
| IL214858A (en) | 2015-05-31 |
| CL2011002278A1 (es) | 2012-03-09 |
| RU2524573C2 (ru) | 2014-07-27 |
| PE20120519A1 (es) | 2012-06-03 |
| KR101665955B1 (ko) | 2016-10-13 |
| CO6450678A2 (es) | 2012-05-31 |
| NZ594923A (en) | 2013-11-29 |
| DOP2011000297A (es) | 2011-10-15 |
| IL214858A0 (en) | 2011-11-30 |
| BRPI1009854A2 (pt) | 2015-08-25 |
| CA2753825C (en) | 2017-10-17 |
| AU2010229975A1 (en) | 2011-09-29 |
| CR20110524A (es) | 2012-01-19 |
| ECSP11011415A (es) | 2011-11-30 |
| MY169288A (en) | 2019-03-21 |
| EP2411372A1 (en) | 2012-02-01 |
| EP2411372B1 (en) | 2014-07-23 |
| RU2011142757A (ru) | 2013-04-27 |
| MX2011010049A (es) | 2011-10-11 |
| CN102361858B (zh) | 2014-07-23 |
| SG174211A1 (en) | 2011-10-28 |
| ZA201106511B (en) | 2012-05-30 |
| AU2010229975B2 (en) | 2015-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL214600A0 (en) | Process for preparing substituted 2-nitrobiphenyls | |
| EP2464650A4 (en) | PROCESSES FOR PREPARING PEMETREXED | |
| IL220357A0 (en) | Process for preparing substituted 1-o-acyl-2-deoxy-2-fluoro-4-thio-beta-d-arabinofuranoses | |
| EP2402313A4 (en) | METHOD FOR PRODUCING A PYRROL COMPOUND | |
| SG10201505540SA (en) | Process for preparing antiviral compounds | |
| EP2415777A4 (en) | PROCESS FOR PRODUCING NUCLEOSIDE | |
| IL222290A0 (en) | Process for preparing aminobenzofuran derivatives | |
| IL222191A0 (en) | Process for preparing sulfonamido-benzofuran derivatives | |
| ZA201102424B (en) | Process for preparing 2-alkyl-3-aroyl-5-nitro-benzofurans | |
| EP2534127A4 (en) | PROCESS FOR PREPARING (R) 2-ACETAMIDO-N-BENZYL-3-METHOXY-PROPIONAMIDE | |
| ZA201207386B (en) | Process for preparing benzoxaboroles | |
| EP2390243A4 (en) | PROCESS FOR PREPARING BISPHENOL | |
| IL218140A0 (en) | Process for preparing 1-phenylpyrazoles | |
| EP2404985A4 (en) | PROCESS FOR PRODUCING LIPID | |
| IL208514A0 (en) | Process for preparing substituted biphenylanilides | |
| IL227220A (en) | A process for preparing a history of 3-alkylsulfinylbenzoyl | |
| HK1166798A1 (en) | Process for preparing an antiviral compound | |
| SI2477964T1 (sl) | Postopek za pripravo derivatov alfa-karboksamida | |
| EP2456778A4 (en) | PROCESS FOR PRODUCING FLUOROCYTIDINE DERIVATIVES | |
| IL207222A0 (en) | Process for preparing hebivolol | |
| PT2245018T (pt) | Processo para preparar bosentano | |
| EP2619174A4 (en) | PROCESS FOR THE PREPARATION OF L-PHENYL-3-DIMETHYLAMINOPROPANE DERIVATIVES | |
| EP2585436A4 (en) | PROCESS FOR THE PREPARATION OF 4-HYDROXYPYRIDINES | |
| IL223145A0 (en) | Process for preparing dithiine-tetracarboxy-diimides | |
| ZA201204825B (en) | Process for preparing biocides |